Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2788921000168116 | linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 14 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2788931000168118 | linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 14 | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 14 | has MPUU | linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet | true | Inferred relationship | Some | 1 | |
| linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 14 | Is a | metformin hydrochloride 850 mg tablet, 14 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trajentamet 2.5 mg/850 mg tablet, 14 | Is a | True | linagliptin 2.5 mg + metformin hydrochloride 850 mg tablet, 14 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR